Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Debt Ratio (2019 - 2026)

Viatris (VTRS) posted Debt Ratio of 0.38 for Q2 2026, down 2.17% on a QoQ basis from 0.39 in Q1 2026, and up 1.12% year-over-year from 0.38 in Q2 2025.

Analysis

Viatris (VTRS) Debt Ratio (2019 - 2026) Analysis & Trends

Viatris has reported Debt Ratio for 8 years, with the latest figure at 0.38 in Q2 2026.

  • On a quarterly basis, Debt Ratio rose 1.12% year-over-year to 0.38 in Q2 2026; TTM through Jun 2026 was 0.38, a 1.12% increase from a year earlier, with the FY2025 full-year figure at 0.39, up 14.5% from the prior year.
  • Debt Ratio was 0.38 for Q2 2026 at Viatris, down from 0.39 in the prior quarter.
  • The five-year high for Debt Ratio was 0.42 in Q2 2022, with the low at 0.34 in Q4 2024.
  • Average Debt Ratio over 5 years is 0.38, with a median of 0.38 recorded in 2025.
  • The sharpest annual moves came in 2024 and 2025: Debt Ratio dropped 10.98% in 2024, then gained 14.5% in 2025.
  • Over 5 years, Debt Ratio stood at 0.39 in 2022, then retreated by 1.32% to 0.38 in 2023, then declined by 10.98% to 0.34 in 2024, then advanced by 14.5% to 0.39 in 2025, then slipped by 1.69% to 0.38 in 2026.
  • The last three Debt Ratio figures came in at 0.38 (Q2 2026), 0.39 (Q1 2026), and 0.39 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 0.42
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 0.38
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 0.13
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 0.71
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 0.87
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 0.85
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 0.20
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 0.35
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.38
Mar 31, 2026 0.39
Dec 31, 2025 0.39
Sep 30, 2025 0.38
Jun 30, 2025 0.38
Mar 31, 2025 0.37
Dec 31, 2024 0.34
Sep 30, 2024 0.35
Jun 30, 2024 0.38
Mar 31, 2024 0.38
Dec 31, 2023 0.38
Sep 30, 2023 0.38
Jun 30, 2023 0.38
Mar 31, 2023 0.38
Dec 31, 2022 0.39
Sep 30, 2022 0.41
Jun 30, 2022 0.42
Mar 31, 2022 0.41
Dec 31, 2021 0.42
Sep 30, 2021 0.42